ABSTRACT NUMBER - 27

IMPROVING CYCLODIODE – A RISK FACTOR ANALYSIS OF COMPLICATIONS


Mr Jaskirat Aujla, Graham Lee, Stephen Vincent

Meeting:  2011 RANZCO


SESSION INFORMATION

Date:      -

Session Title: POSTER ABSTRACTS

Session Time:      -

Purpose:
The purpose of this study is to identify risk factors for developing complications following treat-ment of refractory glaucoma with transscleral diode laser cyclophotocoagulation (cyclodiode), to improve the safety profile of this treatment modality.

Method:
A retrospective analysis of 72 eyes from 70 patients who were treated with cyclodiode.

Results:
The mean pre-treatment IOP was 37.0 mmHg (SD 11.0), with a mean post-treatment reduction in intraocular pressure (IOP) of 19.8 mmHg, and a mean IOP at last follow-up of 17.1 mmHg (SD 9.7). Mean total power delivered during treatment was 156.8 Joules (SD 82.7) over a mean of 1.3 treatments (SD 0.6). Sixteen eyes (22.2% of patients) developed com-plications from the treatment, with the most common being hypotony, occurring in 6 patients, including 4 with neovascular glaucoma. A higher pre-treatment IOP and higher mean total power delivery also were associated with higher complications.

Conclusion:
Cyclodiode is an effective treatment option for glaucoma that is refractory to other treat-ment options. By identifying risk factors for potential complications, cyclodiode can be modified accordingly for each patient to improve safety and efficacy.